Accès ouvert
2026
article
OpenAlex
Dávid Nagy, Zsófia Onódi, Andrea Kovács, Tímea Bálint et autres
BACKGROUND: The inflammasome pathway has been implicated in the progression of heart failure (HF). Preclinical studies suggest that angiotensin receptor-neprilysin inhibitor (ARNi) and sodium-glucose cotransporter-2 inhibitor (SGLT2i) therapies may attenuate inflammasome activation, yet evidence in the failing human myocardium remains sparse. Hence, …
hu
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Florina Zákány, Rosemary Chandrakanthi Kothalawala, Olivér Pavela, Lajos Szente et autres
Molecular-order-related membrane biophysical properties contribute to the functional modulation of transmembrane proteins, and therefore, their changes due to a modified membrane composition in diseases associated with alterations in lipid levels may play important pathophysiological roles. In living cells, membrane biophysics can be …
hu
(code pays fourni par la source)
2026
article
OpenAlex
Attila Bóta, Teréz Kiss, András Wacha, Kinga Ilyés et autres
hu, cz
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Kinga Ilyés, Tasvilla Sonallya, Judith Mihály, Anikó Gaál et autres
High Resolution Image Download MS PowerPoint Slide Extracellular vesicles (EVs) are crucial in many physiological and pathological processes, and therefore, they are increasingly studied for their potential as diagnostic biomarkers, therapeutic agents, and drug carriers. Red-blood-cell-derived EVs (REVs) have gained particular interest …
hu
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Tamas Kovacs, Kitti Kurtan, Bernadett Pályi, Zoltán Kis et autres
ACE2 binding of spike proteins and concomitant viral uptake are the first and most decisive membrane-coupled events of SARS-CoV-2 infection, which rely on cholesterol-rich lipid raft microdomains of the host cell plasma membrane. Therefore, lowering membrane cholesterol levels may combat the infection, …
hu, np
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Tamás G. Gergely, Tamás Kovács, Zsombor I. Hegedűs, Zsófia Onódi et autres
Abstract Introduction Immune checkpoints (ICs) are key regulatory molecules of the adaptive immune response. Immune checkpoint inhibition (ICI) is a novel, revolutionary strategy for the treatment of many cancer types. However, ICIs can lead to various immune-related adverse events, including cardiovascular toxicities, …
hu
(code pays fourni par la source)
2024
article
OpenAlex
ZV Varga, Tamás G. Gergely, Zsófia D. Drobni, Tamás Kovács et autres
Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Momentum grant of the Hungarian Academy of Sciences Introduction Immune checkpoint inhibitors (ICI), such as monoclonal antibodies targeting programmed death ligand-1 (PD-1), revolutionized cancer treatment. However, …
hu, us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
András Makkos, Bence Ágg, ZV Varga, Zoltán Giricz et autres
Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): National Research, Development and Innovation Office of Hungary (NKFIA; NVKP-16-1-2016-0017 National Heart Program and OTKA-FK 134751); MTA-SE System Pharmacology Research Group, Department of Pharmacology and Pharmacotherapy, …
hu, at, de, sk
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
T Gergely, Dániel Kucsera, VE Toth, Balázs Petrovich et autres
Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – EU funding. Main funding source(s): European Union’s Horizon 2020 Research and Innovation Programme under grant agreement no. 739593 “Semmelweis 250+ Kiválósági PhD Ösztöndíj” (EFOP-3.6.3-VEKOP-16-2017-00009) Gedeon Richter Talentum Foundation’s scholarship Background Immune checkpoint …
hu
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Z Gulyas-Onodi, Tamás Visnovitz, Anna Koncz, Balázs Váradi et autres
Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – EU funding. Main funding source(s): European Union's Horizon 2020 research and innovation programme National Research, Development and Innovation Fund of Hungary Background Cardiac cell lines and primary cell cultures are widely used …
hu, pl
(code pays fourni par la source)
2022
article
OpenAlex
Imre Vörös, ZS Onodi, VE Toth, T Gergely et autres
Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – EU funding. Main funding source(s): Horizon 2020 research and innovation programme, Ministry for Innovation and Technology Background Dipeptidyl-peptidase-4 (DPP4) inhibitors are relatively new therapeutic tools for type 2 diabetes. The SAVOR-TIMI-53 clinical …
hu, pl
(code pays fourni par la source)
2022
article
OpenAlex
Dániel Kucsera, Nabil V. Sayour, Mihály Ruppert, Tamás Radovits et autres
Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – EU funding. Main funding source(s): European Union's Horizon 2020 Research and Innovation Programme, grant agreement no. 739593 New National Excellence Program of the Ministry of Human Capacities (ÚNKP-21-3-II) Introduction Heart failure with …
hu
(code pays fourni par la source)